협골 및 익상돌기 임플란트 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the zygomatic and pterygoid implants market size is projected to be USD 264.83 million in 2025, USD 280.34 million in 2026, and reach USD 381.59 million by 2031, growing at a CAGR of 6.36% from 2026 to 2031.

This report is Segmented by Product Type (Zygomatic Implants, Pterygoid Implants), Length of Implant (Up To 30 Mm, 31-50 Mm, Above 50 Mm), Application (Severe Atrophy of Maxillary Bone, and More), Procedure Approach (Immediate Loading, Delayed Loading), End User (Hospitals, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Zygomatic And Pterygoid Implants Market Trends and Insights

Rising Prevalence of Severe Maxillary Atrophy & Edentulism

The World Health Organization noted in 2024 that severe periodontal disease affects 20% of adults, with prevalence spiking among people older than 65 and oncologic survivors. Maxillary atrophy results in vertical and horizontal bone loss, precluding the placement of conventional implants, prompting the adoption of zygomatic and pterygoid solutions that deliver fixed prostheses within weeks. Rapid execution appeals to patients managing diabetes or osteoporosis who cannot tolerate lengthy graft healing. United Nations projections show that the global population aged 65 and older will reach 1.5 billion by 2050, locking in long-term demand.

Clinical Advantage of Graft-Less, Immediate-Loading Rehabilitation

Pooled analyses published by the International Team for Implantology documented a 98.1% survival rate for immediately loaded zygomatic implants. Removing graft steps cuts operating-room time up to 40% and eliminates graft material costs. A 2024 prospective study achieved 100% survival for Straumann's ZAGA implants over 46.5 months, validating predictable outcomes when anatomical protocols are followed. Economic and clinical benefits continue to push immediate loading toward mainstream dominance.

High Procedural & Implant Costs

One arch of zygomatic rehabilitation in North America ranges from USD 15,000 to USD 40,000, 150-200% above standard implant therapy. Major insurers such as Cigna limit coverage to cancer, congenital defects, or trauma, excluding periodontal disease in most circumstances. Patients seek lower-cost destinations abroad, but cross-border care complicates follow-up and warranty enforcement.

Other drivers and restraints analyzed in the detailed report include:

1. Adoption of Digital Dentistry
2. Quad-Zygomatic Protocols Expanding Eligible Patient Pool
3. Steep Surgical Learning Curve & Limited Specialist Base

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Zygomatic implants held 74.02% of 2025 revenue, anchoring most full-arch cases and reinforcing the leadership of NobelZygoma and Straumann ZAGA. Pterygoid implants, while smaller, are expanding 7.29% a year as surgeons combine anterior zygomatic and posterior pterygoid fixation for balanced load distribution. Hybrid demand is set to keep pterygoid share climbing within the zygomatic and pterygoid implants market.

Increasing adoption of pterygoid fixtures reflects documented 95.6% six-year success and the desire to shorten cantilevers in full-arch prostheses. Ongoing training and digital guides are expected to narrow outcome gaps between the two product lines, sustaining healthy rivalry that benefits end users within the zygomatic and pterygoid implants market.

Implants 31-50 mm accounted for 47.87% of 2025 placements, yet lengths above 50 mm are rising fastest at a 9.93% CAGR. The zygomatic and pterygoid implants market share for long fixtures is climbing as clinicians treat patients with severe bone loss or post-oncology maxillectomy. Extended lengths provide bicortical anchorage and exceed 35 N cm insertion torque, prerequisites for immediate loading in the zygomatic and pterygoid implant markets.

Longer implants, offered up to 60 mm by NobelZygoma TiUltra, suit anatomies with aggressive sinus pneumatization. Growth in this category underscores surgeons' confidence in digital navigation to accurately traverse complex trajectories without breaching critical structures.

Complete Report Scope:

• By Product Type
  • Zygomatic Implants
  • Pterygoid Implants
• By Length of Implant
  • Up to 30 mm
  • 31 - 50 mm
  • Above 50 mm
• By Application
  • Severe Atrophy of Maxillary Bone
  • Maxillary Sinuses
  • Trauma & Other Indications
• By Procedure Approach
  • Immediate Loading
  • Delayed Loading
• By End User
  • Hospitals
  • Dental Clinics
  • Ambulatory Surgical Centers
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America contributed 41.23% of 2025 value to the zygomatic and pterygoid implants market. Favorable oncology reimbursement, dense continuing-education networks, and high disposable incomes sustain premium adoption. U.S. private insurers cover cancer-related cases, while Canada's provincial plans subsidize medically necessary reconstructions, creating steady volume.

Europe ranks second. Harmonized CE-marking under MDR eases multicountry rollout; Germany, France, and the United Kingdom anchor core demand, while Spain and Hungary attract cross-border patients seeking 30-50% fee reductions. Currency stability and widespread acceptance of immediate-load dentistry underpin resilient growth despite macroeconomic pressures.

Asia-Pacific is the fastest-growing territory, expanding 9.63% annually. Urban China and India generate sheer volume, whereas Japan and South Korea capture premium case values. Thailand and Singapore leverage medical tourism frameworks, promoting bundled packages that include CBCT, implant surgery, and prosthetic delivery in a single trip, strengthening regional contributions to the zygomatic and pterygoid implants market.

Middle East & Africa present concentrated demand pockets, especially among affluent populations in the Gulf Cooperation Council. Government-funded specialty centers in the United Arab Emirates and Saudi Arabia are recruiting European-trained surgeons to run digital implant suites. South America's upswing is paced by Brazil's large private dental sector and Argentina's cost-competitive clinics, which are drawing Chilean clients, though currency volatility tempers momentum.

1. Adin Dental Implant Systems
2. B&B Dental Implant Co.
3. BioHorizons
4. Bioline Dental Implants
5. Danaher
6. Dentsply Sirona
7. IDC Implant & Dental Co.
8. Implant Swiss
9. JDentalCare
10. Neoss
11. Nobel Biocare (Envista)
12. Noris Medical
13. OsseoSource
14. Osstem Implant
15. S.I.N. Implant System
16. Silimed
17. Southern Implants
18. Straumann Group
19. TitaniumFix
20. Zimmer Biomet

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Prevalence of Severe Maxillary Atrophy & Edentulism
  • 4.2.2 Clinical Advantage of Graft-Less, Immediate-Loading Rehabilitation
  • 4.2.3 Adoption of Digital Dentistry
  • 4.2.4 Quad-Zygomatic Protocols Expanding Eligible Patient Pool
  • 4.2.5 Dental Tourism Surge for Complex Oral Rehabilitation
  • 4.2.6 Pilot Insurer Reimbursements for Oncologic Maxillectomy Cases
• 4.3 Market Restraints
  • 4.3.1 High Procedural & Implant Costs
  • 4.3.2 Steep Surgical Learning Curve & Limited Specialist Base
  • 4.3.3 Post-Operative Sinusitis Management Burden
  • 4.3.4 Regulatory Ambiguity on Extra-Maxillary Anchorage Devices
• 4.4 Regulatory Landscape
• 4.5 Technological Outlook
• 4.6 Porter's Five Forces Analysis
  • 4.6.1 Threat of New Entrants
  • 4.6.2 Bargaining Power of Buyers
  • 4.6.3 Bargaining Power of Suppliers
  • 4.6.4 Threat of Substitute Products
  • 4.6.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts

• 5.1 By Product Type
  • 5.1.1 Zygomatic Implants
  • 5.1.2 Pterygoid Implants
• 5.2 By Length of Implant
  • 5.2.1 Up to 30 mm
  • 5.2.2 31 - 50 mm
  • 5.2.3 Above 50 mm
• 5.3 By Application
  • 5.3.1 Severe Atrophy of Maxillary Bone
  • 5.3.2 Maxillary Sinuses
  • 5.3.3 Trauma & Other Indications
• 5.4 By Procedure Approach
  • 5.4.1 Immediate Loading
  • 5.4.2 Delayed Loading
• 5.5 By End User
  • 5.5.1 Hospitals
  • 5.5.2 Dental Clinics
  • 5.5.3 Ambulatory Surgical Centers
• 5.6 By Geography
  • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
  • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
  • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 Japan
    • 5.6.3.3 India
    • 5.6.3.4 Australia
    • 5.6.3.5 South Korea
    • 5.6.3.6 Rest of Asia-Pacific
  • 5.6.4 Middle East & Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East & Africa
  • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as Available, Strategic Information, Market Rank/Share for Key Companies, Products & Services, and Recent Developments)
  • 6.3.1 Adin Dental Implant Systems
  • 6.3.2 B&B Dental Implant Co.
  • 6.3.3 BioHorizons
  • 6.3.4 Bioline Dental Implants
  • 6.3.5 Danaher Corporation
  • 6.3.6 Dentsply Sirona
  • 6.3.7 IDC Implant & Dental Co.
  • 6.3.8 Implant Swiss
  • 6.3.9 JDentalCare
  • 6.3.10 Neoss
  • 6.3.11 Nobel Biocare (Envista)
  • 6.3.12 Noris Medical
  • 6.3.13 OsseoSource
  • 6.3.14 Osstem Implant
  • 6.3.15 S.I.N. Implant System
  • 6.3.16 Silimed
  • 6.3.17 Southern Implants
  • 6.3.18 Straumann Holding AG
  • 6.3.19 TitaniumFix
  • 6.3.20 Zimmer Biomet

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment